# Egetis - **Website:** - **Primary alias:** `egetis.com` - **Other aliases:** `SE0003815604`, `EGTX.ST` - **Employees:** 11+ - **Location:** Stockholm, Stockholm County, Sweden - **Company kind:** PUBLIC COMPANY ## Description Egetis Therapeutics is an innovative and integrated pharmaceutical company that focuses on developing treatments for serious diseases with significant unmet medical needs in the orphan drug segment. Their lead candidate, Emcitate, is a potential treatment for patients with monocarboxylate transporter 8 (MCT8) deficiency, a rare disease without currently available treatment options. Emcitate has shown highly significant and clinically relevant results in previous studies, and the company plans to submit a marketing authorization application (MAA) to the European Medicines Agency (EMA) in the second quarter of 2023. In the US, Egetis will conduct a small study to verify the results and plans to submit a new drug application (NDA) in the second half of 2023. Emcitate is also being investigated in a Phase II/III study for younger MCT8 deficiency patients. Egetis also has a drug candidate called Aladote, which aims to reduce the risk of acute liver injury associated with paracetamol (acetaminophen) overdose. Egetis Therapeutics is listed on the Nasdaq Stockholm main market. ## Industries - 🏭 Chemical Industry _(under Heavy Industry and Engineering)_ - 🏭 Heavy Industry and Engineering ## Logos & icons - logo _(primary)_ — PNG — [download](https://cdn.brandfetch.io/idqfvj0x14/w/608/h/340/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1781939482088) ## Colors | Name | Hex | Theme | | --- | --- | --- | | Cloud Burst | #1e2c50 | accent | | Dove Gray | #666666 | dark | | Havelock Blue | #59a1da | light | | Allports | #007b9d | accent | ## Fonts - Helvetica — asset _(custom)_ ## Imagery - banner _(primary)_ — JPEG — [download](https://cdn.brandfetch.io/idqfvj0x14/w/1500/h/500/idV9i28raj.jpeg?c=1bxid64Mup7aczewSAYMX&t=1746147615930) --- _Source: _ _See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._